A new trading day began on Tuesday, with Avidity Biosciences Inc (NASDAQ: RNA) stock price down -0.92% from the previous day of trading, before settling in for the closing price of $31.64. RNA’s price has ranged from $8.86 to $56.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 148.90% over the past five years. Meanwhile, its annual earnings per share averaged 1.49%. With a float of $108.55 million, this company’s outstanding shares have now reached $118.90 million.
Let’s look at the performance matrix of the company that is accounted for 253 employees. In terms of profitability, gross margin is 80.79%, operating margin of -3209.35%, and the pretax margin is -2772.45%.
Avidity Biosciences Inc (RNA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Avidity Biosciences Inc is 9.02%, while institutional ownership is 101.10%. The most recent insider transaction that took place on Dec 18 ’24, was worth 416,154. In this transaction CSTO of this company sold 12,742 shares at a rate of $32.66, taking the stock ownership to the 72,647 shares. Before that another transaction happened on Dec 18 ’24, when Company’s Chief Financial Officer sold 11,151 for $32.66, making the entire transaction worth $364,192. This insider now owns 82,942 shares in total.
Avidity Biosciences Inc (RNA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 1.49% per share during the next fiscal year.
Avidity Biosciences Inc (NASDAQ: RNA) Trading Performance Indicators
Here are Avidity Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 17.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 369.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.90, a number that is poised to hit -0.79 in the next quarter and is forecasted to reach -3.21 in one year’s time.
Technical Analysis of Avidity Biosciences Inc (RNA)
Avidity Biosciences Inc (NASDAQ: RNA) saw its 5-day average volume 1.68 million, a positive change from its year-to-date volume of 1.31 million. As of the previous 9 days, the stock’s Stochastic %D was 23.66%. Additionally, its Average True Range was 2.19.
During the past 100 days, Avidity Biosciences Inc’s (RNA) raw stochastic average was set at 4.94%, which indicates a significant decrease from 14.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.61% in the past 14 days, which was lower than the 65.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.83, while its 200-day Moving Average is $37.27. Nevertheless, the first resistance level for the watch stands at $31.70 in the near term. At $32.04, the stock is likely to face the second major resistance level. The third major resistance level sits at $32.39. If the price goes on to break the first support level at $31.00, it is likely to go to the next support level at $30.65. Assuming the price breaks the second support level, the third support level stands at $30.31.
Avidity Biosciences Inc (NASDAQ: RNA) Key Stats
With a market capitalization of 3.74 billion, the company has a total of 119,309K Shares Outstanding. Currently, annual sales are 9,560 K while annual income is -212,220 K. The company’s previous quarter sales were 2,340 K while its latest quarter income was -80,400 K.
